EGFR and prostate carcinoma: C4-2B (metastatic derivative of LNCaP) prostate cancer cells pretreated with curcumin had lower levels of ligand-mediated epidermal growth factor receptor (EGFR) autophosphorylation when compared to the control, consequently hindering the EGFR ligand from promoting downstream signaling [48].